Aurobindo Pharma Ltd is pleased to announce that the Company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Fluconazole Tablets 50mg, 100mg, 150mg and 200mg.
Fluconazole Tablets is the generic version of Pfizer Diflucan® tablets 50mg, 100mg 150mg and 200mg and is indicated for the treatment of fungal infections.
This is Aurobindo's 80th ANDA approval from the USFDA.
The Stock closed the day at Rs.195, down by Rs.15.95 or 7.56%. The stock hit an intraday high of Rs.203.20 and low of Rs.182.
The total traded quantity was 51575 compared to 2 week average of 37490.
|